Büyüme Hormonunun Metabolik ve Yaşam Kalitesine Etkileri

Abstract

Büyüme hormonunun primer etkisi lineer büyümeyi hızlandırmasıdır. Bunun dışında protein, yağ ve karbonhidrat metabolizmasını da regüle etmektedir. Protein sentezini artırırken, lipolizi hızlandırır, kan şekerini yükseltir. Kemik olgunlaşmasıyla birlikte kemik mineral dansitesini artırır. Eritropoezi artırırken, serum ferritin düzeyini düşürür. Karaciğerde yapımını artırdığı IGF-1 hücre içine aminoasit ve glukoz taşınmasını artırır. Aşırı artan IGF-1 mitojenik etkilere yol açabilir. Büyüme hormonu kullanımı ile depresyon azalır, özgüven artar ve bozuk olan yaşam kalitesi yükselir.

Keywords

• Büyüme hormonu, Depresyon, IGF-1, Metabolik, Yaşam kalitesi

The Effects of Growth Hormone on Metabolic Changes and Quality of Life

Abstract

The major effect of growth hormone is acceleration of linear growth. It also regulates protein, carbohydrate, and lipid metabolism. Growth hormone increases protein synthesis, lipolysis, and serum glucose levels. It increases bone mineral density by increasing bone maturation. Growth hormone increases erythropoiesis and decreases serum ferritin levels. IGF-1 that is produced in the liver by growth hormone causes an increase in the transportation of amino acids and glucose into cells. Excessively increased IGF-1 may cause mitogenic effects. Growth hormone treatment aids in decreasing depression, increasing self-esteem and quality of life

Keywords

• Growth hormone, Depression, IGF-1, Metabolic, Quality of life

References

1. Jorgensen JO, Pedersen SA, Thuesen L, et al. Beneficial effects of growth hormone treatment in GH-deficient adults. Lancet 1989; 1:1221-5.
2. Salomon F, Cueno RC, Hesp R, Sönksen PH. The effects of treatment with recombinant human growth hormone on body composition and metabolism in adults with growth hormone deficiency. N Eng J Med 1989;321:1797-1803.
3. Attanasio AF, Shavrikova E, Blum VF, et al. Continued growth hormone (GH) treatment after final height is necessary to complete somatic development in childhood-onset GH- deficient patients. J Clin Endocrinol Metab 2004;89:4857-62.
4. Ross J, Czernichow P, Biler BMK, et al. Growth hormone: Healthy considerations beyond health gain. Pediatrics 2010;125: e906-e918.
5. Randhawa R, Cohen P. The role of the insulin-like factor system in prenatal growth. Mol Genet Metab 2005;86:84-90.
6. Kurtoglu S, Atabek ME, Gunes T, Akcakus M, Keskin M, Kocaoglu C. Relationship between cord blood levels of IGF-1 and ferritin in healthy term neonates. J Pediatr Endocrinol Metab 2004;17: 737-742.
7. Boot AM, Engels MA, Boerma GJ, Krenning EP, De Muinck Keizer- Schrama SM. Changes in bone mineral density, body composition, and lipid metabolism during growth hormone (GH) treatment in children with GH deficiency. J Clin Endocrinol Metab 1997;82: 2423-2428.
8. Roemmich JN, Huerta MG, Sundaresan SM, Rogol AD. Alterations in body composition and fat distrubution in growth hormone- deficient prepubertal children during growth hormone therapy. Metabolism 2001;50:537-47.

9. Schweizer R, Martin DD, Haase M, Roth J, Trebar B, Binder G, et al. Similar effects of long-term exogenous growth hormone (GH) on bone and muscle parameters: A pQCT study of GH –deficient and small-for-gestational age (SGA) children. Bone 2007;41:875-81.
10. Root AW, Kemp SF, Rundle AC, Dana K, Attie KM. Effect of long- term recombinant growth hormone therapy in children- the National Cooperative Growth Study, USA, 1985-1994. J Pediatr Endocrinol Metab 1998;11:403-12.
11. Colao A, Di Somma C, Salerno M, Spinelli L, Orio F, Lombardi G. The cardiovascular risk of GH-deficient adolescents. J Clin Endocrinol Metab 2002;87:3650-5.
12. Lanes R, Paoli M, Carrillo E, Villaroel O, Palacios A. Cardiovascular risk of young growth- hormonw-deficient adolescents: Differen- ces in growth-hormone-treated and untreated patients. Horm Res 2003;60:291-6.
13. van der Sluis IM, Boot AM, Hop WC, De Rijke YB, Krenning EP, de Muinck Keizer-Schrama SM. Long-term effects of growth hormone therapy on bone mineral density, body composition, and serum lipid levels in growth hormone deficient children: A 6-year follow-up study. Horm Res 2002;58:207-14.
14. Högler W, Briody J, Moore B, Lu PW, Cowell CT. Effect of growth hormone therapy and puberty on bone and body composition in children with idiopathic short stature and growth hormone deficiency. Bone 2005;37:642-50.
15. Şıklar Z, Öçal G, Berberoğlu M, Bilir P. BH tedavisinde güvenlik indeksi olarak IGF-1 ve IGFBP-3’ün birlikte değerlendirilmesi ve boy kazanımı ile karşılaştırılması. Kongre kitabı, XIII. Ulusal Pediatrik Endokrin ve Diyabet Kongresi, 17-21 Kasım 2009, Antalya, Türkiye.128.
16. Taback SP, Dean HJ. Mortality in Canadian children with growth hormone(GH) deficiency receiving GH therapy 1967-1992. The Canadian Growth Hormone Advisory Committe. J Clin Endocrinol Metab 1996;81:1693-6.
17. Spielhagen C, Schwahn C, Möller K, Friedrich N, Kohlmann T, Moock J, et al. The benefit of long-term growth hormone(GH) replacement therapy in hypopituitary adults with growth hormone deficiency: Results of the German KIMS database. Growth Hormone IGF Research 2011;21:1-10.
18. Sandberg DE, Voss LD. The psychological consequences of short stature: A review of the evidence. Best Pract Res Clin Endocrinol Metab 2002;16:449-63.
19. Stabler B, Clopper RR, Siegel PT, Stoppani C, Compton PG, Underwood LE. Academic achievement and psychological adjustment in short children. The National Cooperative Growth Study. J Dev Behav Pediatr 1994;15:1-6.
20. Abe S, Okumura A, Mukae T, Nakazawa T, Niijima S, Yamashiro Y, et al. Depressive tendency in children with growth hormone deficiency. J Paediatr Child Health 2009;45:636-40.
21. van Pareren YK, Duivenvoorden HJ, Slijper FS, Koot HM, Hokken- Koelega AC. Intelligence and psychological functioning during long-term growth hormone therapy in children born small for gestational age. J Clin Endocrinol Metab 2004;89:5295-302.
22. Chaplin JE, Kriström B, Jonsson B, Hägglöf B, Tuvemo T, Aronson AS, et al. Improvements in behaviour and self-esteem following growth hormone treatment in short prepubertal children. Horm Res Paediatr 2011;75:291-303.
23. Bideci A, Soysal Ş. Büyüme hormonu eksikliği olan hastalarda yaşam kalitesinin boylamsal değerlendirilmesi (Yayınlanmamış veriler, çok merkezli çalışma).